“…Abnormalities in orexin signaling pathways underlie the pathophysiology of sleep disorders (Baumann and Bassetti, 2005a, b; Cao and Guilleminault, 2011; Dyken and Yamada, 2005; Malhotra and Kushida, 2013; Mignot, 2004; Overeem et al, 2001; Ritchie et al, 2010; Tafti et al, 2005; Taheri et al, 2002; Wisor and Kilduff, 2005; Zeitzer, 2013) such as narcolepsy (Nishino et al, 2000; Peyron et al, 2000; Thannickal et al, 2000) and may contribute to posttraumatic hypersomnia or excessive daytime sleepiness due to traumatic brain injury (Baumann, 2012; Baumann et al, 2009), post traumatic stress disorder (Strawn et al, 2010), or obstructive sleep apnea (Ahmed et al, 2012; Wang et al, 2013). Insufficient central orexin signaling has also been associated with other medical conditions (Mignot et al, 2002; Vankova et al, 2003) such as obesity (Van Cauter and Knutson, 2008), age-related anorexia (Kmiec et al, 2013), multiple system atrophy (Benarroch et al, 2007), neurological disorders (Fronczek et al, 2009), Parkinson’s disease (Fronczek et al, 2007; Thannickal et al, 2007; Wienecke et al, 2012), and Alzheimer’s disease (Slats et al, 2013).…”